Publications by authors named "B Weigmann"

Background: Tofacitinib, as inhibitor of Janus kinases (JAK), interrupts the transmission of numerous pro-inflammatory cytokines involved in the pathogenesis of inflammatory bowel diseases (IBD). Therefore, tofacitinib provides a potent option to treat ulcerative colitis (UC). Besides the anti-inflammatory potential, inhibition of widespread JAKs carries the risk of side effects.

View Article and Find Full Text PDF
Article Synopsis
  • Inflammatory bowel disease (IBD) is an autoimmune condition causing severe bowel issues, with unclear causes and no current effective treatments.
  • A study investigated the effects of a combination of flavonoids, specifically apigenin and EGCG, on IBD and found they boosted intestinal barrier function and reduced inflammation in lab and animal models.
  • The flavonoid treatment not only lowered harmful pro-inflammatory cytokines but also increased beneficial anti-inflammatory cytokines and positively changed gut microbiota, suggesting a potential new therapy for IBD.
View Article and Find Full Text PDF

The immune microenvironment plays an important role in the regulation of diseases. The characterization of the cellular composition of immune cell infiltrates in diseases and respective models is a major task in pathogenesis research and diagnostics. For the assessment of immune cell populations in tissues, fluorescence-activated cell sorting (FACS) or immunohistochemistry (IHC) are the two most common techniques presently applied, but they are cost intensive, laborious, and sometimes limited by the availability of suitable antibodies.

View Article and Find Full Text PDF